Active quarter for Diamyd Medical
In today’s quarterly report Diamyd Medical’s President and CEO, Elisabeth Lindner, comments on the very active period the company has had during the last part of 2008.During the last quarter the company has focused on meeting and negotiating with both the scientific and financial sector. On the scientific side the company achieved one of its milestones; the successful Phase II study with children and adolescents with type 1 diabetes was published in the prestigious medical journal the New England Journal of Medicine. Together with leading diabetes researchers the company has also applied to